| Current state of target treatment in BRAF mutated melanoma ET Tanda, I Vanni, A Boutros, V Andreotti, W Bruno, P Ghiorzo, ... Frontiers in molecular biosciences 7, 154, 2020 | 111 | 2020 |
| Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy P Queirolo, A Boutros, E Tanda, F Spagnolo, P Quaglino Seminars in cancer biology 59, 290-297, 2019 | 106 | 2019 |
| Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis L Arecco, E Blondeaux, M Bruzzone, M Ceppi, MM Latocca, C Marrocco, ... Human Reproduction 37 (5), 954-968, 2022 | 81 | 2022 |
| Non-BRAF mutant melanoma: molecular features and therapeutical implications I Vanni, ET Tanda, B Dalmasso, L Pastorino, V Andreotti, W Bruno, ... Frontiers in Molecular Biosciences 7, 172, 2020 | 44 | 2020 |
| The adjuvant treatment revolution for high-risk melanoma patients F Spagnolo, A Boutros, E Tanda, P Queirolo Seminars in Cancer Biology 59, 283-289, 2019 | 41 | 2019 |
| Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysis A Boutros, M Bruzzone, ET Tanda, E Croce, L Arecco, F Cecchi, ... European Journal of Cancer 159, 154-166, 2021 | 36 | 2021 |
| The treatment of advanced melanoma: Current approaches and new challenges A Boutros, E Croce, M Ferrari, R Gili, G Massaro, R Marconcini, L Arecco, ... Critical Reviews in Oncology/Hematology 196, 104276, 2024 | 33 | 2024 |
| Targeting the DNA damage response pathway as a novel therapeutic strategy in colorectal cancer F Catalano, R Borea, S Puglisi, A Boutros, A Gandini, M Cremante, ... Cancers 14 (6), 1388, 2022 | 32 | 2022 |
| Immunotherapy for the treatment of cutaneous squamous cell carcinoma A Boutros, F Cecchi, ET Tanda, E Croce, R Gili, L Arecco, F Spagnolo, ... Frontiers in oncology 11, 733917, 2021 | 32 | 2021 |
| How to protect ovarian function before and during chemotherapy? L Arecco, T Ruelle, V Martelli, A Boutros, MM Latocca, S Spinaci, ... Journal of Clinical Medicine 10 (18), 4192, 2021 | 31 | 2021 |
| Merkel cell carcinoma: an immunotherapy fairy-tale? ET Tanda, AL d’Amato, G Rossi, E Croce, A Boutros, F Cecchi, ... Frontiers in Oncology 11, 739006, 2021 | 28 | 2021 |
| Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization L Mastracci, V Fontana, P Queirolo, R Carosio, F Grillo, A Morabito, ... Cancer Immunology, Immunotherapy 69 (4), 653-662, 2020 | 25 | 2020 |
| Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis A Boutros, ET Tanda, E Croce, F Catalano, M Ceppi, M Bruzzone, ... European Journal of Cancer 188, 64-79, 2023 | 24 | 2023 |
| Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review F Spagnolo, A Boutros, F Cecchi, E Croce, ET Tanda, P Queirolo BMC cancer 21, 1-14, 2021 | 24 | 2021 |
| Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review F Spagnolo, A Boutros, E Croce, F Cecchi, L Arecco, E Tanda, P Pronzato, ... European journal of clinical investigation 51 (7), e13604, 2021 | 22 | 2021 |
| Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature A Boutros, A Bottini, G Rossi, ET Tanda, F Spagnolo, G Barletta, E Croce, ... ESMO open 8 (1), 100791, 2023 | 15 | 2023 |
| Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis L Arecco, E Blondeaux, M Bruzzone, MM Latocca, E Mariamidze, ... ESMO open 8 (6), 102031, 2023 | 14 | 2023 |
| Case report: immune-related toxicity during adjuvant treatment with BRAF plus MEK inhibitors in a melanoma patient A Boutros, C Schiavi, F Cecchi, F Spagnolo, A Guadagno, ET Tanda, ... Frontiers in Immunology 11, 579523, 2020 | 11 | 2020 |
| Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology P Queirolo, M Cinquini, G Argenziano, F Bassetto, P Bossi, A Boutros, ... ESMO open 8 (6), 102037, 2023 | 7 | 2023 |
| Medical Treatment of Melanoma: Adjuvant and Neoadjuvant Therapies F Spagnolo, E Tanda, A Boutros, F Cecchi, P Queirolo Current Management of Melanoma, 157-165, 2021 | 6 | 2021 |
